{"id":28455,"date":"2024-03-25T07:31:47","date_gmt":"2024-03-25T07:31:47","guid":{"rendered":"https:\/\/fipmed.co\/common-fip-comorbidities\/"},"modified":"2024-03-25T07:31:47","modified_gmt":"2024-03-25T07:31:47","slug":"common-fip-comorbidities","status":"publish","type":"page","link":"https:\/\/fipmed.co\/sk\/common-fip-comorbidities\/","title":{"rendered":"9 be\u017en\u00fdch komorbid\u00edt FIP"},"content":{"rendered":"<h2>Pre\u010do sa FIP \u010dasto vyskytuje spolu s in\u00fdmi ochoreniami?<\/h2>\n<p>Ma\u010dky s in\u00fdmi ochoreniami ako FIP s\u00fa \u010dasto n\u00e1hodne pozit\u00edvne na protil\u00e1tky proti FCoV alebo na v\u00edrus. Tu je 9 be\u017en\u00fdch komorbid\u00edt FIP. FIP m\u00f4\u017ee by\u0165 d\u00f4sledkom oslabenia imunitn\u00e9ho syst\u00e9mu v d\u00f4sledku u\u017e existuj\u00facich ochoren\u00ed, mut\u00e1cie v\u00edrusu alebo p\u00f4vodn\u00e9ho ochorenia, ktor\u00e9 sp\u00f4sobuje \u010fal\u0161ie komplik\u00e1cie. <\/p>\n<h3>Predch\u00e1dzaj\u00faci stav<\/h3>\n<p>Predch\u00e1dzaj\u00face ochorenie m\u00f4\u017ee sp\u00f4sobi\u0165, \u017ee ma\u010dky bud\u00fa n\u00e1chylnej\u0161ie na FIP &#8211; ovplyvn\u00ed to ich celkov\u00fd zdravotn\u00fd stav a kvalitu \u017eivota. Je to preto, \u017ee in\u00e9 ochorenia alebo oslaben\u00fd imunitn\u00fd syst\u00e9m m\u00f4\u017eu by\u0165 pr\u00ed\u010dinou mut\u00e1cie v\u00edrusu, ktor\u00fd sp\u00f4sobuje FIP. Predch\u00e1dzaj\u00face ochorenia nemusia by\u0165 v\u017edy zjavn\u00e9, hoci niektor\u00e9 be\u017en\u00e9 pr\u00edznaky m\u00f4\u017eu zah\u0155\u0148a\u0165 hor\u00fa\u010dku, stratu hmotnosti, letargiu, anorexiu a dehydrat\u00e1ciu &#8211; v\u0161etky tieto pr\u00edznaky s\u00fa indik\u00e1tormi bakteri\u00e1lnych infekci\u00ed. Ak sa to zist\u00ed v\u010das, antibiotik\u00e1 alebo doplnkov\u00e1 v\u00fd\u017eiva m\u00f4\u017eu pom\u00f4c\u0165 zmierni\u0165 \u010fal\u0161ie po\u0161kodenie u\u017e aj tak oslaben\u00e9ho stavu ma\u010dky. Okrem toho je d\u00f4le\u017eit\u00e9 udr\u017eiava\u0165 aktu\u00e1lne o\u010dkovanie, ktor\u00e9 by mohlo sl\u00fa\u017ei\u0165 aj ako ochrana pred mo\u017en\u00fdm sekund\u00e1rnym v\u00fdvojom sp\u00f4soben\u00fdm u\u017e existuj\u00facimi ochoreniami, ako je napr\u00edklad FIP. <\/p>\n<h3>Mut\u00e1cia v\u00edrusu<\/h3>\n<p>Mut\u00e1cie prote\u00ednu hrotu v\u00edrusu, ktor\u00fd je hlavnou s\u00fa\u010das\u0165ou ma\u010dacieho koronav\u00edrusu, m\u00f4\u017eu sp\u00f4sobi\u0165 zmeny v sp\u00f4sobe \u0161\u00edrenia a replik\u00e1cie v\u00edrusu. Ak s\u00fa v tomto konkr\u00e9tnom prote\u00edne pr\u00edtomn\u00e9 mut\u00e1cie, zvy\u0161uje sa schopnos\u0165 FIP infikova\u0165 ma\u010dky, ako aj z\u00e1va\u017enos\u0165 n\u00e1kazy. Okrem toho m\u00f4\u017eu tieto v\u00fdkyvy zasahova\u0165 do in\u00fdch procesov naj\u010dastej\u0161ie spojen\u00fdch s funkciou buniek imunitn\u00e9ho syst\u00e9mu, \u010do vedie k abnorm\u00e1lnym v\u00fdsledkom pravideln\u00e9ho v\u00fdvoja ochorenia. V d\u00f4sledku toho sa r\u00f4zne sprievodn\u00e9 ochorenia spojen\u00e9 s FIP, ako napr\u00edklad z\u00e1pal p\u013e\u00fac, chronick\u00e9 ochorenie obli\u010diek (CKD), v\u00edrus ma\u010dacej leuk\u00e9mie (FeLV), rakovina alebo autoimunitn\u00e9 ochorenia, m\u00f4\u017eu rozvin\u00fa\u0165 vo vy\u0161\u0161ej miere, ako sa o\u010dak\u00e1valo, v d\u00f4sledku oslaben\u00fdch imunitn\u00fdch reakci\u00ed sp\u00f4soben\u00fdch spom\u00ednan\u00fdmi v\u00edrusov\u00fdmi mut\u00e1ciami, ktor\u00e9 u\u017e v bunk\u00e1ch existuj\u00fa. <\/p>\n<h3>Po\u010diato\u010dn\u00e1 choroba sp\u00f4soben\u00e1 slab\u00fdm imunitn\u00fdm syst\u00e9mom<\/h3>\n<p>Ak m\u00e1 ma\u010dka infekciu, imunitn\u00fd syst\u00e9m m\u00f4\u017ee by\u0165 oslaben\u00fd. Toto oslabenie imunity potom vedie k vy\u0161\u0161iemu riziku vzniku FIP. Stresy prostredia m\u00f4\u017eu tie\u017e oslabi\u0165 imunitn\u00fd syst\u00e9m a zv\u00fd\u0161i\u0165 n\u00e1chylnos\u0165 na infekcie FIPV. Najm\u00e4 ma\u010dky s infekciou FeLV (v\u00edrusom leuk\u00e9mie ma\u010diek) s\u00fa n\u00e1chylnej\u0161ie na v\u00edrus FIP ako ostatn\u00e9 zdrav\u00e9 ma\u010dky, preto\u017ee ich oslaben\u00fd imunitn\u00fd syst\u00e9m nedok\u00e1\u017ee \u00fa\u010dinne bojova\u0165 proti nov\u00fdm v\u00edrusom. Mlad\u00e9 ma\u010dky a ma\u010dky, ktor\u00e9 u\u017e maj\u00fa oslaben\u00fa imunitu, m\u00f4\u017eu ma\u0165 probl\u00e9my s bojom proti katastrofick\u00fdm v\u00edrusov\u00fdm infekci\u00e1m, ako je FIPV.  <\/p>\n<p>&nbsp;<\/p>\n<h2>Z\u00e1pal p\u013e\u00fac a FIP<\/h2>\n<p>Pneum\u00f3nia je be\u017enou komorbiditou spojenou s FIP u ma\u010diek. To znamen\u00e1, \u017ee ak m\u00e1 va\u0161a ma\u010dka FIP, pravdepodobne bude ma\u0165 v r\u00e1mci infekcie aj z\u00e1pal p\u013e\u00fac. Z\u00e1pal p\u013e\u00fac vznik\u00e1, ke\u010f z\u00e1pal zablokuje d\u00fdchacie cesty ved\u00face do p\u013e\u00fac a m\u00f4\u017ee postihn\u00fa\u0165 ak\u00fdko\u013evek vek alebo plemeno ma\u010dky. U ma\u010diek s FIP sa m\u00f4\u017ee vyvin\u00fa\u0165 pneum\u00f3nia, preto\u017ee v\u00edrusov\u00e9 \u010dastice FCoV sp\u00f4sobuj\u00fa z\u00e1palov\u00fa reakciu, ktor\u00e1 m\u00f4\u017ee vies\u0165 k \u0165a\u017ekostiam s d\u00fdchan\u00edm a ka\u0161\u013eaniu v d\u00f4sledku nahromadenia tekutiny v p\u013e\u00facach a pohrudni\u010dn\u00fdch, resp. bru\u0161n\u00fdch dutin\u00e1ch. Pr\u00edznaky z\u00e1palu p\u013e\u00fac sa zvy\u010dajne objavia do dvoch t\u00fd\u017ed\u0148ov od vystavenia ma\u010daciemu koronav\u00edrusu, vr\u00e1tane straty chuti do jedla, letargie, hor\u00fa\u010dky, zr\u00fdchlen\u00e9ho d\u00fdchania, zv\u00fd\u0161enej srdcovej frekvencie, nam\u00e1hav\u00e9ho d\u00fdchania (zn\u00e1meho ako dyspnoe), \u00fabytku hmotnosti a vyka\u0161liavania krvav\u00e9ho hlienu.  <\/p>\n<h2><strong>CKD a FIP<\/strong><\/h2>\n<p>Ma\u010dky s chronick\u00fdm ochoren\u00edm obli\u010diek (CKD) s\u00fa vystaven\u00e9 zv\u00fd\u0161en\u00e9mu riziku vzniku FIP, potenci\u00e1lne smrte\u013enej v\u00edrusovej infekcie. \u0160t\u00fadie uk\u00e1zali, \u017ee ma\u010dky trpiace nediagnostikovanou alebo zle lie\u010denou CKD m\u00f4\u017eu ma\u0165 vy\u0161\u0161iu pravdepodobnos\u0165 ochorenia na FIP v d\u00f4sledku oslabenia imunitn\u00e9ho syst\u00e9mu sp\u00f4soben\u00e9ho predch\u00e1dzaj\u00facim ochoren\u00edm. V skuto\u010dnosti sa CKD be\u017ene demaskuje, ke\u010f sa u postihnut\u00e9ho zviera\u0165a objav\u00ed FIP &#8211; \u010do nazna\u010duje, \u017ee bola pr\u00edtomn\u00e1 u\u017e pred prejaven\u00edm pr\u00edznakov FIP. To nazna\u010duje vz\u0165ah medzi t\u00fdmito dvoma chorobami a to, ako sa m\u00f4\u017eu navz\u00e1jom negat\u00edvne ovplyv\u0148ova\u0165. Na\u0161\u0165astie, v\u010dasn\u00e1 diagnostika CKS a FIP m\u00f4\u017ee ma\u010dk\u00e1m prinies\u0165 lep\u0161ie v\u00fdsledky, preto\u017ee r\u00fdchla lie\u010dba oboch ochoren\u00ed by mohla spomali\u0165 progresiu oboch ochoren\u00ed a zlep\u0161i\u0165 pr\u00edznaky s nimi spojen\u00e9, ako je zlyhanie obli\u010diek alebo hor\u00fa\u010dka. <\/p>\n<h2>FELV a FIP<\/h2>\n<p>Infekcia v\u00edrusom ma\u010dacej leuk\u00e9mie (FeLV) je \u010dast\u00fdm sprievodn\u00fdm ochoren\u00edm FIP. V\u00e4\u010d\u0161ina ma\u010diek, u ktor\u00fdch sa vyvinie FIP, m\u00e1 u\u017e existuj\u00face ochorenie alebo infekciu, ako je FeLV, \u010do ich rob\u00ed n\u00e1chylnej\u0161\u00edmi na v\u00edrusy a in\u00e9 infek\u010dn\u00e9 agensy. Mut\u00e1cia v\u00edrusu m\u00f4\u017ee vies\u0165 k oport\u00fannym infekci\u00e1m v oslabenom imunitnom syst\u00e9me, \u010do vedie k rozvoju ochorenia. Ak je infekcia FeLV pr\u00edtomn\u00e1 pri FIP, u mnoh\u00fdch infikovan\u00fdch ma\u010diek sa vyskytuje hlbok\u00e1 panleukop\u00e9nia &#8211; pokles bielych krviniek, ktor\u00fd oslabuje imunitu ma\u010dky. Tento typ an\u00e9mie sp\u00f4sobuje drastick\u00fd pokles hladiny krvn\u00fdch do\u0161ti\u010diek a zvy\u0161uje krehkos\u0165 \u017e\u00edl a tepien, \u010do vedie k probl\u00e9mom s krv\u00e1can\u00edm v celom tele. Medzi \u010fal\u0161ie stavy spojen\u00e9 s FeLV patria malignity, imunosupresia a zv\u00fd\u0161en\u00e1 v\u00edrusov\u00e1 z\u00e1\u0165a\u017e postihnut\u00fdch ma\u010diek, \u010do s\u00fa v\u0161etko faktory, ktor\u00e9 prispievaj\u00fa k v\u00fdrazn\u00e9mu zhor\u0161eniu ich zdravotn\u00e9ho stavu po diagnostikovan\u00ed FIP. <\/p>\n<h2>Rakovina a FIP<\/h2>\n<p>Ma\u010dky, u ktor\u00fdch sa vyvinie rakovina alebo ma\u010dacia neopl\u00e1zia, m\u00f4\u017eu by\u0165 rovnako n\u00e1chyln\u00e9 na in\u00e9 s\u00fabe\u017en\u00e9 ochorenia, ako je napr\u00edklad FIP. Hoci neexistuj\u00fa d\u00f4kazy, ktor\u00e9 by nazna\u010dovali priamu s\u00favislos\u0165 medzi rakovinou a FIP u ma\u010diek, odborn\u00edci uzn\u00e1vaj\u00fa zv\u00fd\u0161en\u00fa zranite\u013enos\u0165 niektor\u00fdch ma\u010diek s rakovinou, ktor\u00e9 sa z\u00e1rove\u0148 nakazia FIP. Slab\u0161\u00ed imunitn\u00fd syst\u00e9m t\u00fdch, ktor\u00e9 s\u00fa infikovan\u00e9 jedn\u00fdm z t\u00fdchto ochoren\u00ed, pravdepodobne prispieva k tomu, \u017ee sa obe ochorenia vyskytuj\u00fa naraz. Pr\u00edznaky sa m\u00f4\u017eu do ur\u010ditej miery prekr\u00fdva\u0165 v z\u00e1vislosti od konkr\u00e9tnych typov rakoviny a kme\u0148a v\u00edrusu, ktor\u00fd sa podie\u013ea na FIP, napr\u00edklad chronick\u00fd \u00fabytok hmotnosti\/prib\u00fadanie na v\u00e1he, letargia, celkovo nev\u00fdrazn\u00fd zdravotn\u00fd stav, opakuj\u00face sa epiz\u00f3dy hor\u00fa\u010dky alebo probl\u00e9my s d\u00fdchan\u00edm sa vyskytuj\u00fa u postihnut\u00fdch ma\u010diek pri oboch ochoreniach s\u00fa\u010dasne. Vzh\u013eadom na skuto\u010dnos\u0165, \u017ee tieto dve ochorenia maj\u00fa niektor\u00e9 spolo\u010dn\u00e9 ukazovatele, definit\u00edvna diagn\u00f3za si zvy\u010dajne vy\u017eaduje kompletn\u00e9 vy\u0161etrenie krvn\u00e9ho obrazu, ktor\u00e9 veterin\u00e1rnym lek\u00e1rom umo\u017e\u0148uje lep\u0161iu anal\u00fdzu povahy a rozsahu infekci\u00ed. <\/p>\n<h2>Autoimunitn\u00e9 ochorenia a FIP<\/h2>\n<p>Majitelia ma\u010diek si musia by\u0165 vedom\u00ed potenci\u00e1lnych rizikov\u00fdch faktorov spojen\u00fdch s FIP, z ktor\u00fdch jedn\u00fdm m\u00f4\u017eu by\u0165 autoimunitn\u00e9 ochorenia. Autoimunitn\u00e9 ochorenia sa u ma\u010diek vyskytuj\u00fa vtedy, ke\u010f protil\u00e1tky organizmu nap\u00e1daj\u00fa vlastn\u00e9 tkaniv\u00e1 a org\u00e1ny namiesto cudz\u00edch l\u00e1tok, ako s\u00fa bakt\u00e9rie a v\u00edrusy. Tento oslaben\u00fd stav imunitn\u00e9ho syst\u00e9mu sp\u00f4sobuje v\u00e4\u010d\u0161iu zranite\u013enos\u0165 vo\u010di infekci\u00e1m, ako je FIP. Okrem toho u\u017e existuj\u00face stavy sp\u00f4soben\u00e9 autoimunitn\u00fdmi poruchami m\u00f4\u017eu vytvori\u0165 prostredie pre mut\u00e1ciu koronav\u00edrusov, ktor\u00e9 s\u00fa p\u00f4vodne ne\u0161kodn\u00e9, ale m\u00f4\u017eu sa vyvin\u00fa\u0165 do FIP a sp\u00f4sobi\u0165 po\u0161kodenie buniek v \u017eivotne d\u00f4le\u017eit\u00fdch org\u00e1noch. Vzh\u013eadom na to, \u017ee ide o ochorenie pren\u00e1\u0161an\u00e9 vzduchom, aj zdrav\u00e9 ma\u010dky bez ak\u00fdchko\u013evek predch\u00e1dzaj\u00facich ochoren\u00ed m\u00f4\u017eu by\u0165 st\u00e1le ohrozen\u00e9, ak boli vystaven\u00e9 infikovanej ma\u010dke, ktor\u00e1 si \u0165apkala po nose alebo k\u00fdchala v ich bl\u00edzkosti. <\/p>\n<h2>Bakteri\u00e1lna infekcia a FIP<\/h2>\n<p>Majitelia ma\u010diek by si mali uvedomi\u0165, \u017ee bakteri\u00e1lne infekcie m\u00f4\u017eu zohr\u00e1va\u0165 \u00falohu pri vzniku a progresii FIP. Okrem toho nelie\u010den\u00e1 bakteri\u00e1lna infekcia m\u00f4\u017ee e\u0161te viac oslabi\u0165 imunitn\u00fd syst\u00e9m ma\u010dky, \u010do vedie k tomu, \u017ee v pr\u00edpade infekcie r\u00fdchlej\u0161ie pod\u013eahne FIP.<\/p>\n<h2>FHV a FIP<\/h2>\n<p>Ak je ma\u010dka infikovan\u00e1 ma\u010dac\u00edm herpesv\u00edrusom (FHV) aj FIP, m\u00f4\u017ee \u00eds\u0165 o obzvl\u00e1\u0161\u0165 z\u00e1va\u017en\u00fd pr\u00edpad. FHV oslabuje schopnos\u0165 organizmu bojova\u0165 proti in\u00fdm chorob\u00e1m, tak\u017ee ma\u010dky s\u00fa n\u00e1chylnej\u0161ie na ochorenie na in\u00e9 infekcie, ako je FIP. Okrem toho m\u00f4\u017eu pr\u00edznaky ochorenia postupova\u0165 r\u00fdchlej\u0161ie v d\u00f4sledku oslabenia imunitn\u00e9ho syst\u00e9mu. Je to preto, \u017ee v z\u00e1vislosti od kme\u0148a vybran\u00e9ho g\u00e9novou mut\u00e1ciou, ak s\u00fa pr\u00edtomn\u00e9 dva p\u00f4vodcovia, ako napr\u00edklad FHV a FIP v tomto pr\u00edpade, s\u00fa\u010dasne prispievaj\u00fa k z\u00e1palu a sp\u00f4sobuj\u00fa \u010fal\u0161ie \u0161kodliv\u00e9 priame \u00fa\u010dinky vlastn\u00fdch replika\u010dn\u00fdch cyklov vo vn\u00fatri buniek. <\/p>\n<h2>FIV a FIP<\/h2>\n<p>V\u00fdskyt v\u00edrusu FIV (v\u00edrus ma\u010dacej imunodeficiencie) aj FIP m\u00f4\u017ee v\u00fdrazne zv\u00fd\u0161i\u0165 zdravotn\u00e9 rizik\u00e1 pre ma\u010dky, preto\u017ee existuje mo\u017enos\u0165 dvojitej infekcie. To, \u017eia\u013e, zvy\u0161uje riziko v\u00e1\u017enych komplik\u00e1ci\u00ed, ako je zlyhanie org\u00e1nov, strata hmotnosti a dokonca aj smr\u0165. Z tohto d\u00f4vodu je d\u00f4le\u017eit\u00e9, aby majitelia ma\u010diek dali svoje zviera testova\u0165, ak maj\u00fa podozrenie na niektor\u00fa z t\u00fdchto chor\u00f4b. Hlavn\u00fdm probl\u00e9mom, ktor\u00fd nast\u00e1va pri v\u00fdskyte FIV aj FPV u ma\u010diek, je, \u017ee sa t\u00fdm v\u00fdrazne oslabuje imunitn\u00fd syst\u00e9m zviera\u0165a, \u010do ho rob\u00ed n\u00e1chylnej\u0161\u00edm na choroby alebo infekcie sp\u00f4soben\u00e9 bakt\u00e9riami alebo v\u00edrusmi. Ak s\u00fa ma\u010dky infikovan\u00e9 dvoma ochoreniami naraz, m\u00f4\u017ee to zhor\u0161i\u0165 pr\u00edznaky a tie\u017e skomplikova\u0165 mo\u017enosti lie\u010dby. V niektor\u00fdch pr\u00edpadoch m\u00f4\u017ee ma\u010dka spo\u010diatku vykazova\u0165 pr\u00edznaky len jedn\u00e9ho ochorenia &#8211; nesk\u00f4r sa v\u0161ak v d\u00f4sledku oslabenej imunity \u010dasom vyvin\u00fa obe ochorenia spolu &#8211; preto je k\u013e\u00fa\u010dov\u00e9 sledova\u0165 v\u010dasn\u00e9 varovn\u00e9 pr\u00edznaky, ako je hor\u00fa\u010dka \u00fanava a zv\u00fd\u0161en\u00e1 frekvencia d\u00fdchania.<\/p>\n<h2>FIP po\u010das tehotenstva<\/h2>\n<p>FIP po\u010das gravidity je pre ma\u010dku a jej ma\u010diatka obzvl\u00e1\u0161\u0165 nebezpe\u010dn\u00e1. FIP sa m\u00f4\u017ee vyskytn\u00fa\u0165 u mal\u00e9ho po\u010dtu gravidn\u00fdch ma\u010diek, \u010do vedie k z\u00e1va\u017enej \u00famrtnosti matky aj vrhu nenaroden\u00fdch ma\u010diatok. Toto ochorenie r\u00fdchlo postupuje s malou \u0161ancou na uzdravenie, preto\u017ee ma\u010dky infikovan\u00e9 t\u00fdmto v\u00edrusom trpia hromaden\u00edm tekutiny v telesn\u00fdch dutin\u00e1ch, nehybnos\u0165ou \u010driev, zlyhan\u00edm obli\u010diek, po\u0161koden\u00edm pe\u010dene alebo z\u00e1palom in\u00fdch org\u00e1nov. \u010co je e\u0161te hor\u0161ie, aj ke\u010f je plod v neskor\u0161\u00edch \u0161t\u00e1di\u00e1ch gravidity, ke\u010f jeho matka ochorie na FIP, e\u0161te na\u017eive, m\u00f4\u017ee pod\u013eahn\u00fa\u0165 v d\u00f4sledku nedostato\u010dnej v\u00fd\u017eivy sp\u00f4sobenej oslaben\u00fdm stavom matky. Vzh\u013eadom na to, ak\u00e1 kritick\u00e1 m\u00f4\u017ee by\u0165 infekcia FIP po\u010das gravidity pre matku aj postihnut\u00e9 deti, majitelia by mali r\u00fdchlo vyh\u013eada\u0165 lek\u00e1rsku pomoc, ak spozoruj\u00fa ak\u00e9ko\u013evek pr\u00edznaky s\u00favisiace s t\u00fdmto ochoren\u00edm po\u010das gravidity svojej ma\u010dky.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pre\u010do sa FIP \u010dasto vyskytuje spolu s in\u00fdmi ochoreniami? Ma\u010dky s in\u00fdmi ochoreniami ako FIP s\u00fa \u010dasto n\u00e1hodne pozit\u00edvne na protil\u00e1tky proti FCoV alebo na v\u00edrus. Tu je 9 be\u017en\u00fdch komorbid\u00edt FIP. FIP m\u00f4\u017ee by\u0165 d\u00f4sledkom oslabenia imunitn\u00e9ho syst\u00e9mu v d\u00f4sledku u\u017e existuj\u00facich ochoren\u00ed, mut\u00e1cie v\u00edrusu alebo p\u00f4vodn\u00e9ho ochorenia, ktor\u00e9 sp\u00f4sobuje \u010fal\u0161ie komplik\u00e1cie. Predch\u00e1dzaj\u00faci stav [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":28456,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_glsr_average":0,"_glsr_ranking":0,"_glsr_reviews":0,"footnotes":""},"categories":[1175],"tags":[],"_links":{"self":[{"href":"https:\/\/fipmed.co\/sk\/wp-json\/wp\/v2\/pages\/28455"}],"collection":[{"href":"https:\/\/fipmed.co\/sk\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/fipmed.co\/sk\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/fipmed.co\/sk\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/fipmed.co\/sk\/wp-json\/wp\/v2\/comments?post=28455"}],"version-history":[{"count":0,"href":"https:\/\/fipmed.co\/sk\/wp-json\/wp\/v2\/pages\/28455\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fipmed.co\/sk\/wp-json\/wp\/v2\/media\/28456"}],"wp:attachment":[{"href":"https:\/\/fipmed.co\/sk\/wp-json\/wp\/v2\/media?parent=28455"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fipmed.co\/sk\/wp-json\/wp\/v2\/categories?post=28455"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fipmed.co\/sk\/wp-json\/wp\/v2\/tags?post=28455"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}